UP!
 |
|
|
Type
|
Subsidiary of Broadcom Limited |
|---|---|
| Traded as | Formerly NYSE: ELX |
| Industry | Technology |
| Founded | 1978 |
| Headquarters | Costa Mesa, California, United States |
|
Key people
|
Bruce C. Edwards (Executive chairman) Jeff Benck (CEO) |
| Revenue |  US$478.60 million (2013) |
|
Net income
|
 −US$5.21 million (2013) |
| Total equity | US$761.8 million (2009) |
|
Number of employees
|
More than 1200 (2013) |
| Website | www.Avagotech.com |
Emulex Corporation provides network connectivity, monitoring and management hardware and software. The company's I/O connectivity offerings, including its line of Ethernet and Fibre Channel-based connectivity products, were used in server and storage products from OEMs, including Cisco, Dell, EMC Corporation, Fujitsu, Hitachi, HP, Huawei, IBM, NetApp and Oracle Corporation.
In 2013, Emulex acquired Endace, based in New Zealand.
Headquartered in Costa Mesa, California, Emulex was founded in 1978 and employed more than 1200 people in 2013.
On April 21, 2009, Broadcom made a proposal to the Emulex board of directors to buy all existing shares of Emulex for $764 million, or $9.25 per share, a 40% premium over the stock's closing price on April 20, 2009. After Emulex's board of directors recommended against the sale, Broadcom increased the company's offer to $11 per share on June 30, which valued the company at $925 million. It too was rejected on July 9, 2009. Subsequently, Broadcom announced it would withdraw its offer. In February 2015, Avago Technologies Limited (which later merged with Broadcom) announced it would acquire Emulex Corporation for $8 per share in cash.
| 2015-01-16 | Reiterated Rating | BMO Capital Markets | Market Perform | $7.00 |
| 2015-01-13 | Reiterated Rating | Summit Research | Hold | $6.00 |
| 2014-10-10 | Upgrade | DA Davidson | Underperform to Neutral | $5.50 to $5.00 |
| 2014-08-04 | Downgrade | Barclays | Equal Weight to Underweight | $7.00 to $6.00 |
| 2014-08-04 | Downgrade | Barclays PLC | Equal Weight to Underweight | $7.00 to $6.00 |
| 2014-05-02 | Downgrade | DA Davidson | Underperform | |
| 2014-05-01 | Downgrade | DA Davidson | Neutral to Underperform | $10.00 to $5.00 |
| 2014-05-01 | Downgrade | Summit Research | Buy to Hold | |
| 2014-05-01 | Downgrade | Stephens | Overweight to Equal Weight | $10.00 to $7.00 |
| 2014-05-01 | Downgrade | Piper Jaffray | Overweight to Neutral | $10.00 to $6.00 |
| 2014-05-01 | Downgrade | Bank of America | Buy to Underperform | $8.50 to $5.00 |
| 2014-05-01 | Lower Price Target | RBC Capital | Sector Perform | $8.00 to $7.00 |
| 2014-03-14 | Initiated Coverage | DA Davidson | Buy | $10.00 |
| 2014-03-13 | Initiated Coverage | DA Davidson | Buy | $10.00 |
| 2014-01-31 | Boost Price Target | JPMorgan Chase & Co. | Underweight | $8.00 to $8.50 |
| 2014-01-31 | Boost Price Target | BMO Capital Markets | Market Perform | $8.00 to $8.50 |
| 2014-01-16 | Upgrade | Bank of America | Underperform to Buy | $5.75 to $8.50 |
| 2013-12-20 | Initiated Coverage | Edison Investment Research | Positive | |
| 2013-11-12 | Upgrade | Piper Jaffray | Neutral to Overweight | $8.00 to $9.00 |
| 2013-10-31 | Boost Price Target | JPMorgan Chase & Co. | Underweight | $6.50 to $8.00 |
| 2013-10-31 | Boost Price Target | Barclays | Equal Weight | $8.00 to $9.00 |
| 2013-10-31 | Reiterated Rating | BMO Capital Markets | Market Perform | $7.00 to $8.00 |
| 2013-09-20 | Reiterated Rating | Lazard Capital Markets | Buy | |
| 2013-09-20 | Upgrade | Craig Hallum | Hold to Buy | |
| 2011-07-14 | Upgrade | Morgan Keegan | Mkt Perform to Outperform | $13.50 to $11 |
| 2010-11-11 | Reiterated | Wedbush | Neutral | $12 to $14 |
| 2010-08-04 | Downgrade | Jefferies | Buy to Hold | $12 to $10 |
| 2010-06-15 | Upgrade | Wedbush | Underperform to Neutral | $11 to $12 |
| 2010-06-08 | Reiterated | Wedbush | Underperform | $14 to $11 |
| 2015-01-16 | Reiterated Rating | BMO Capital Markets | Market Perform | $7.00 |
| 2015-01-13 | Reiterated Rating | Summit Research | Hold | $6.00 |
| 2014-10-10 | Upgrade | DA Davidson | Underperform to Neutral | $5.50 to $5.00 |
| 2014-08-04 | Downgrade | Barclays | Equal Weight to Underweight | $7.00 to $6.00 |
| 2014-08-04 | Downgrade | Barclays PLC | Equal Weight to Underweight | $7.00 to $6.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ELX 2 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Dynamic Technology Lab Pte Ltd | 70842 |
| Dominick & Dominick LLC | 19250 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| ELLIOTT INTERNATIONAL, L.P. | 7.20% (5801778) | AA / BTU / CTXS / ELX / MITL / NBHC / |
| ELLIOTT ASSOCIATES, L.P. | 3.87% (3124149) | AA / BTU / CTXS / ELX / MITL / NBHC / |
| ROCKENBACH MICHAEL J E V P C F O | 0.45% (363087) | ELX / |
| MCCLUNEY JAMES M C E O | 0.26% (207217) | ELX / MFLX / |
| WARWICK JOHN SVP, Operations | 0.17% (138800) | ELX / MXWL / |
| Benck Jeff President & COO | 0.16% (132194) | ELX / LTRX / NLST / |
| EVASHENK MARGARET A SVP & Chief Dev. Executive | 0.14% (109826) | ELX / |
| DOWNEY MICHAEL P | 0.12% (94013) | ELX / |
| WESCOAT KYLE B SVP, CFO, & Treasurer | 0.11% (86272) | ELX / SKUL / |
| HOOGENBOOM JEFFERY L SVP, Worldwide Sales | 0.11% (86045) | ELX / |
| GOON ROBERT H | 0.09% (72013) | ELX / |
| LYLE DON M | 0.09% (72013) | ELX / |
| WICK RANDALL G SVP, General Counsel | 0.07% (53771) | ELX / |
| FRANTZ EUGENE | 0.05% (43074) | ELX / |
| Mulligan Perry SVP Operations | 0.03% (26900) | ELX / MVIS / QLGC / |
| Clark Gregory S. | 0.01% (9399) | ELX / IMPV / SYMC / |
| NAZARI NERSI | 0.01% (9399) | ELX / |
| FOLINO PAUL F | 0.01% (9399) | CLGX / ELX / LTRX / MSCC / |
| KELLEY JOHN A | 0.01% (9399) | ELX / PLCM / |
| INFANTE BEATRIZ V | 0.01% (9399) | ELX / LQDT / PSMT / SONS / UTEK / |
| Merchant Rahul N | 0.01% (9399) | ELX / FICO / JNPR / |
| Yoost Dean A | 0.01% (9399) | BDC / ELX / |
| Daichendt Gary James | 0.01% (9399) | ELX / JNPR / NCR / PLCM / SHOR / |
UM